rss
J Clin Pathol 2008;61:1013-1017 doi:10.1136/jcp.2008.056317
  • Review

Complement deficiency and disease

  1. D J Unsworth
  1. Dr D J Unsworth, Department of Immunology and Immunogenetics, Southmead Hospital, Bristol BS10 5ND, UK; joe.unsworth{at}nbt.nhs.uk
  • Accepted 7 April 2008
  • Published Online First 21 May 2008

Abstract

There are approximately 30 serum complement proteins (15% of the globulin fraction), excluding cell surface receptors, and regulatory proteins. Many are manufactured in the liver, and reduced complement is a feature of severe liver failure. Complement proteins contribute to the acute phase response, and high levels are seen in chronic untreated inflammation (eg, rheumatoid arthritis). Once activated, complement is strongly pro-inflammatory. Indeed, almost half of the complement system proteins/receptors play regulatory roles, reflecting the importance of controlling inappropriate activation. This review focuses on disease states arising as a direct consequence of complement deficiency or dysfunction.

Footnotes

  • Competing interests: None.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.